Evidence map›Paper›PMID 42894491›Full record

ArticleMolecular nutrition & food research2026

Bitter 2,5-Diketopiperazines From Cocoa Activate Human Bitter Taste Receptors.

Silvia Schaefer, Adolfo Luna, Maik Behrens

Abstract read
In one paragraph

Article in Molecular nutrition & food research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Silvia SchaeferTUM Graduate School, TUM School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Adolfo LunaTUM Graduate School, TUM School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Maik BehrensLeibniz Institute for Food Systems Biology at the Technical University of Munich, Freising, Germany.

Funding

Deutsche Forschungsgemeinschaft BE 2091/7-1
6 · The paper itself

Abstract

The human taste system enables a rapid analysis of nutritional and non-nutritional food constituents. Although a bitter taste is considered a warning signal against ingesting potentially harmful substances, not all bitter substances are toxic, and a moderate bitterness is frequently tolerated or even preferred. Responsible for the detection of bitter substances in food are the ∼25 human bitter taste receptors residing in the oral cavity. An important class of bitter compounds found in thermally treated foods is the 2,5-diketopiperazines, cyclic dipeptides made from two L-amino acids, which are frequently formed as degradation products of polypeptides. Although 2,5-diketopiperazines are established as major contributors to the bitter taste of many food items, it is still unknown which of the human bitter taste receptors mediate their detection. Using functional calcium-mobilization assays, we identified two human bitter taste receptors, TAS2R14 and TAS2R43, being responsive to 2,5-diketopiperazines. Of the two identified 2,5-diketopiperazines activating TAS2R43, cis-cyclo(L-Leu-L-Phe) exhibited the highest potency with a threshold concentration of 100 µM. Further testing of 2,5-diketopiperazine-related linear dipeptides revealed that 2,5-diketopiperazines represent their own class of bitter compounds, as no overlapping activation patterns with the corresponding dipeptides were evident.

Indexed as

DiketopiperazinesReceptors, G-Protein-CoupledTasteHEK293 CellsHumansTaste Receptors, Type 2DiketopiperazinesReceptors, G-Protein-CoupledTaste Receptors, Type 22,5‐diketopiperazinebitter taste receptorcalcium‐mobilization assayG protein‐coupled receptor

Identifiers

PMID42894491
PMCPMC13678406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.